-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$190.2151.06% Upside
Recent Analyst Forecasts and Stock Ratings
Ascendis Pharma A/S Frequently Asked Questions
-
What analysts cover Ascendis Pharma A/S?
Ascendis Pharma A/S has been rated by research analysts at Bank of America Securities, Evercore ISI, Oppenheimer, Citigroup, Wells Fargo, Goldman Sachs in the past 90 days.